Raymond James Trust’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$659K Buy
8,249
+3
+0% +$225 0.01% 653
2024
Q2
$591K Sell
8,246
-174
-2% -$12.8K 0.01% 649
2024
Q1
$593K Buy
8,420
+730
+9% +$52.2K 0.01% 647
2023
Q4
$593K Buy
7,690
+656
+9% +$43.2K 0.02% 617
2023
Q3
$479K Sell
7,034
-18
-0.3% -$1.42K 0.01% 658
2023
Q2
$576K Buy
7,052
+276
+4% +$22.2K 0.02% 604
2023
Q1
$503K Buy
6,776
+947
+16% +$73K 0.02% 634
2022
Q4
$483K Sell
5,829
-375
-6% -$29.8K 0.02% 612
2022
Q3
$440K Buy
6,204
+308
+5% +$26.6K 0.02% 626
2022
Q2
$511K Buy
5,896
+32
+0.5% +$3K 0.02% 580
2022
Q1
$635K Buy
5,864
+432
+8% +$44.6K 0.02% 547
2021
Q4
$703K Sell
5,432
-316
-5% -$38.7K 0.02% 533
2021
Q3
$696K Sell
5,748
-620
-10% -$75.5K 0.02% 502
2021
Q2
$717K Sell
6,368
-236
-4% -$24.8K 0.02% 491
2021
Q1
$631K Buy
6,604
+740
+13% +$67.5K 0.02% 502
2020
Q4
$466K Buy
5,864
+932
+19% +$67.5K 0.02% 571
2020
Q3
$306K Buy
4,932
+600
+14% +$39K 0.01% 685
2020
Q2
$286K Buy
+4,332
New +$259K 0.01% 679

Other funds holding TECH

Raymond James Trust's TECH Position: Q3 2024 in Review

Raymond James Trust increased its Bio-Techne (TECH) stake by 0.04% in Q3 2024, buying an estimated $225 and bringing the position to 8,249 shares worth $659K. The position accounts for 0.01% of the portfolio, ranked #653.

Raymond James Trust first reported a position in TECH in Q2 2020 and has held it in 18 quarters since. The position peaked at $717K in Q2 2021. 561 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • Raymond James Trust held 8,249 shares of Bio-Techne worth $659K as of Q3 2024.
  • Raymond James Trust bought 3 Bio-Techne shares in Q3 2024, an estimated $225.
  • Bio-Techne made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #653 holding.
  • Raymond James Trust first reported a position in Bio-Techne in Q2 2020 and has held it in 18 quarters since.
  • Raymond James Trust's Bio-Techne position peaked at $717K in Q2 2021.
  • 561 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.